William Plovanic
Stock Analyst at Canaccord Genuity
(2.15)
# 3,133
Out of 4,556 analysts
639
Total ratings
41.7%
Success rate
0.4%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Maintained: Buy | $55 | $34.51 | +59.40% | 36 | Jun 29, 2026 | |
| AORT Artivion | Maintained: Buy | $36 | $24.94 | +44.35% | 11 | Jun 29, 2026 | |
| TMDX TransMedics Group | Rated: Buy | $124 | $74.29 | +66.91% | 55 | Jun 29, 2026 | |
| HTFL HeartFlow | Maintained: Buy | $37 | $25.44 | +45.44% | 13 | Jun 29, 2026 | |
| TLSI TriSalus Life Sciences | Maintained: Buy | $7 | $4.34 | +61.29% | 19 | Jun 24, 2026 | |
| PLSE Pulse Biosciences | Initiated Coverage: Buy | $32 | $30.26 | +5.75% | 1 | Jun 4, 2026 | |
| PEN Penumbra | Maintained: Hold | $374 | $317.39 | +17.84% | 30 | Jun 2, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $71 → $70 | $43.19 | +62.07% | 41 | Jun 1, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $180 → $152 | $109.00 | +39.45% | 34 | Jun 1, 2026 | |
| DXCM DexCom | Reiterated: Buy | $100 → $82 | $74.75 | +9.70% | 44 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.97 | +101.21% | 37 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $25 | $17.89 | +39.74% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $17.60 | +98.86% | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 → $249 | $163.72 | +52.09% | 43 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 → $85 | $84.55 | +0.53% | 38 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.88 | +59.57% | 30 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $25 | $8.30 | n/a | 8 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $79 | $76.09 | n/a | 20 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $25 | $17.04 | n/a | 3 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $19 | $14.22 | n/a | 10 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $40.26 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $295 → $300 | $314.58 | n/a | 22 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $150 → $131 | $88.92 | n/a | 14 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.66 → $7 | $11.88 | n/a | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $30.21 | n/a | 6 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $27.10 | n/a | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $43 | $24.27 | n/a | 17 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $70 | $73.48 | n/a | 17 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $1.27 | n/a | 10 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.30 | n/a | 7 | Feb 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.32 | n/a | 11 | Jan 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $7.25 | n/a | 6 | Nov 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $22 | - | n/a | 7 | Jul 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0002 | n/a | 6 | Feb 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $63 | $79.85 | n/a | 7 | Jun 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $7.07 | n/a | 4 | Jul 31, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $11.63 | n/a | 1 | Sep 9, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.01 | n/a | 1 | Jun 28, 2011 |
AtriCure
Jun 29, 2026
Maintained: Buy
Price Target: $55
Current: $34.51
Upside: +59.40%
Artivion
Jun 29, 2026
Maintained: Buy
Price Target: $36
Current: $24.94
Upside: +44.35%
TransMedics Group
Jun 29, 2026
Rated: Buy
Price Target: $124
Current: $74.29
Upside: +66.91%
HeartFlow
Jun 29, 2026
Maintained: Buy
Price Target: $37
Current: $25.44
Upside: +45.44%
TriSalus Life Sciences
Jun 24, 2026
Maintained: Buy
Price Target: $7
Current: $4.34
Upside: +61.29%
Pulse Biosciences
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $30.26
Upside: +5.75%
Penumbra
Jun 2, 2026
Maintained: Hold
Price Target: $374
Current: $317.39
Upside: +17.84%
Boston Scientific
Jun 1, 2026
Reiterated: Buy
Price Target: $71 → $70
Current: $43.19
Upside: +62.07%
iRhythm Holdings
Jun 1, 2026
Maintained: Buy
Price Target: $180 → $152
Current: $109.00
Upside: +39.45%
DexCom
May 19, 2026
Reiterated: Buy
Price Target: $100 → $82
Current: $74.75
Upside: +9.70%
May 12, 2026
Reiterated: Buy
Price Target: $10
Current: $4.97
Upside: +101.21%
May 12, 2026
Reiterated: Buy
Price Target: $28 → $25
Current: $17.89
Upside: +39.74%
May 8, 2026
Maintained: Buy
Price Target: $35
Current: $17.60
Upside: +98.86%
May 7, 2026
Maintained: Buy
Price Target: $435 → $249
Current: $163.72
Upside: +52.09%
Apr 24, 2026
Maintained: Hold
Price Target: $87 → $85
Current: $84.55
Upside: +0.53%
Apr 6, 2026
Maintained: Buy
Price Target: $3
Current: $1.88
Upside: +59.57%
Jan 22, 2024
Maintained: Buy
Price Target: $22 → $25
Current: $8.30
Upside: n/a
Jan 22, 2024
Maintained: Buy
Price Target: $71 → $79
Current: $76.09
Upside: n/a
Jan 22, 2024
Maintained: Buy
Price Target: $24 → $25
Current: $17.04
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $17 → $19
Current: $14.22
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $15
Current: $40.26
Upside: n/a
Dec 15, 2023
Maintained: Hold
Price Target: $295 → $300
Current: $314.58
Upside: n/a
Dec 15, 2023
Maintained: Hold
Price Target: $150 → $131
Current: $88.92
Upside: n/a
Dec 7, 2023
Upgraded: Buy
Price Target: $3.66 → $7
Current: $11.88
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: $32
Current: $30.21
Upside: n/a
Nov 7, 2023
Maintained: Buy
Price Target: $65
Current: $27.10
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: $48 → $43
Current: $24.27
Upside: n/a
Aug 28, 2023
Maintained: Hold
Price Target: $86 → $70
Current: $73.48
Upside: n/a
Feb 23, 2023
Maintained: Buy
Price Target: $16 → $20
Current: $1.27
Upside: n/a
Feb 2, 2016
Maintained: Buy
Price Target: $8
Current: $1.30
Upside: n/a
Jan 11, 2016
Reiterated: Buy
Price Target: $12
Current: $4.32
Upside: n/a
Nov 5, 2015
Maintained: Buy
Price Target: $16
Current: $7.25
Upside: n/a
Jul 29, 2015
Reiterated: Hold
Price Target: $25 → $22
Current: -
Upside: n/a
Feb 2, 2015
Reiterated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Jun 5, 2014
Maintained: Buy
Price Target: $73 → $63
Current: $79.85
Upside: n/a
Jul 31, 2013
Reiterated: Hold
Price Target: $17 → $14
Current: $7.07
Upside: n/a
Sep 9, 2011
Maintained: Buy
Price Target: $45
Current: $11.63
Upside: n/a
Jun 28, 2011
Reiterated: Buy
Price Target: n/a
Current: $19.01
Upside: n/a